Tech Company Financing Transactions
Vir Biotechnology Funding Round
Private investors participated in a $66 million capital raise for Vir Biotechnology. The round was recorded on 7/2/2018.
Transaction Overview
Company Name
Announced On
7/2/2018
Transaction Type
Venture Equity
Amount
$66,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
499 Illinois 500
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Undisclosed
Website
Email Address
Overview
Vir integrates diverse innovations in science, technology, and medicine to transform the care of people with serious infectious diseases. Vir is taking a multi-program, multi-platform approach to applying these breakthroughs, including the development of treatments that induce protective and therapeutic immune responses.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 7/2/2018: Project 2020 venture capital transaction
Next: 7/2/2018: Dataminr venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs